Immune-Mediated Liver Injury

ABSTRACT

Diseases with different pathogeneses share common pathways of immune-mediated injury. Autoreactive T cells destroy hepatocytes or cholangiocytes in autoimmune disease and virus-specific T cells destroy infected hepatocytes in viral hepatitis. In these conditions, antigen-specific mechanisms can be implicated but immune-mediated injury is central to diseases where there is a less-defined role for specific antigens. In all these diseases, “bystander cells” activated by the local microenvironment rather than a specific antigen are major players and amplify effector responses by recruiting natural killer and natural killer T cells, macrophages, neutrophils, eosinophils, and even platelets. Immune-mediated liver injury is driven by repeated cycles of inflammation and damage sustained by continuing recruitment, retention, and survival of effector leukocytes within the inflamed liver. These processes depend on complex interactions involving epithelial cells, stromal cells, and leukocytes shaped by the local cytokine microenvironment. Understanding these interactions will elucidate the pathogenesis of liver disease and suggest new therapies.

KEYWORDS

Inflammation - hepatitis - cell trafficking - chemokines - TNF - CD40

REFERENCES

• 1 Crispe I N, Giannandrea M, Klein I, John B, Sampson B, Wuensch S. Cellular and molecular mechanisms of liver tolerance.  Immunol Rev. 2006;  213 101-118
• 2 Sakaguchi S. Naturally arising CD4 + regulatory T cells for immunologic self-tolerance and negative control of immune responses.  Annu Rev Immunol. 2004;  22 531-562
• 3 Knolle P A, Limmer A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells.  Trends Immunol. 2001;  22 432-437
• 4 Bowen D G, McCaughan G W, Bertolino P. Intrahepatic immunity: a tale of two sites?.  Trends Immunol. 2005;  26 512-517
• 5 Willberg C, Barnes E, Klenerman P. HCV immunology-death and the maiden T cell.  Cell Death Differ. 2003;  10(suppl 1) S39-47
• 6 Kyewski B, Klein L. A central role for central tolerance.  Annu Rev Immunol. 2006;  24 571-606
• 7 Ruprecht C R, Gattorno M, Ferlito F et al.. Coexpression of CD25 and CD27 identifies FoxP3 + regulatory T cells in inflamed synovia.  J Exp Med. 2005;  201 1793-1803
• 8 Seddiki N, Santner-Nanan B, Martinson J et al.. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.  J Exp Med. 2006;  203 1693-1700
• 9 Huehn J, Siegmund K, Lehmann J C et al.. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4 + regulatory T cells.  J Exp Med. 2004;  199 303-313
• 10 Agarwal K, Czaja A J, Jones D E, Donaldson P T. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.  Hepatology. 2000;  31 49-53
• 11 Longhi M S, Hussain M J, Mitry R R et al.. Functional study of CD4 + CD25 + regulatory T cells in health and autoimmune hepatitis.  J Immunol. 2006;  176 4484-4491
• 12 Rushbrook S M, Ward S M, Unitt E et al.. Regulatory T cells suppress in vitro proliferation of virus-specific CD8 + T cells during persistent hepatitis C virus infection.  J Virol. 2005;  79 7852-7859
• 13 Unitt E, Rushbrook S M, Marshall A et al.. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.  Hepatology. 2005;  41 722-730
• 14 Eksteen B, Miles A, Curbishley S M et al.. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10.  J Immunol. 2006;  177 593-603
• 15 Kakimi K, Lane T E, Wieland S et al.. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.  J Exp Med. 2001;  194 1755-1766
• 16 Curbishley S M, Eksteen B, Gladue R P, Lalor P, Adams D H. CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow.  Am J Pathol. 2005;  167 887-899
• 17 Lan R Y, Cheng C, Lian Z X et al.. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.  Hepatology. 2006;  43 729-737
• 18 Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.  Hepatology. 2007;  45 475-485
• 19 Wiegard C, Frenzel C, Herkel J, Kallen K J, Schmitt E, Lohse A W. Murine liver antigen presenting cells control suppressor activity of CD4 + CD25 + regulatory T cells.  Hepatology. 2005;  42 193-199
• 20 Westendorf A M, Templin M, Geffers R et al.. CD4 + T cell mediated intestinal immunity: chronic inflammation versus immune regulation.  Gut. 2005;  54 60-69
• 21 Doherty D G, Norris S, Madrigal-Estebas L et al.. The human liver contains multiple populations of NK cells, T cells, and CD3 + CD56 + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.  J Immunol. 1999;  163 2314-2321
• 22 Kronenberg M, Rudensky A. Regulation of immunity by self-reactive T cells.  Nature. 2005;  435 598-604
• 23 Ajuebor M N, Hogaboam C M, Le T, Swain M G. C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse.  J Immunol. 2003;  170 5252-5259
• 24 Ajuebor M N, Aspinall A I, Zhou F et al.. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.  J Immunol. 2005;  174 8027-8037
• 25 Goddard S, Youster J, Morgan E, Adams D H. Interleukin-10 secretion differentiates dendritic cells from human liver and skin.  Am J Pathol. 2004;  164 511-519
• 26 Lian Z X, Okada T, He X S et al.. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations.  J Immunol. 2003;  170 2323-2330
• 27 Bowen D G, Zen M, Holz L, Davis T, McCaughan G W, Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.  J Clin Invest. 2004;  114 701-712
• 28 Kudo S, Matsuno K, Ezaki T, Ogawa M. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation.  J Exp Med. 1997;  185 777-784
• 29 Yoneyama H, Matsuno K, Zhang Y et al.. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease.  J Exp Med. 2001;  193 35-49
• 30 Bosma B M, Metselaar H J, Mancham S et al.. Characterization of human liver dendritic cells in liver grafts and perfusates.  Liver Transpl. 2006;  12 384-393
• 31 Warren A, Le Couteur D G, Fraser R, Bowen D G, McCaughan G W, Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells.  Hepatology. 2006;  44 1182-1190
• 32 Limmer A, Ohl J, Kurts C et al.. Efficient presentation of exogenous antigen by liver endothelial cells to CD8 + T cells results in antigen-specific T-cell tolerance.  Nat Med. 2000;  6 1348-1354
• 33 Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle P A, Hamann A, Crispe I N. Immunomodulatory effects of the liver: deletion of activated CD4 + effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization.  J Immunol. 2002;  169 2407-2413
• 34 Limmer A, Ohl J, Wingender G et al.. Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance.  Eur J Immunol. 2005;  35 2970-2981
• 35 Klein I, Crispe I N. Complete differentiation of CD8 + T cells activated locally within the transplanted liver.  J Exp Med. 2006;  203 437-447
• 36 John B, Klein I, Crispe I N. Immune role of hepatic TLR-4 revealed by orthotopic mouse liver transplantation.  Hepatology. 2007;  45 178-186
• 37 Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver.  J Exp Med. 2003;  198 39-50
• 38 Klugewitz K, Adams D H, Emoto M, Eulenburg K, Hamann A. The composition of intrahepatic lymphocytes: shaped by selective recruitment?.  Trends Immunol. 2004;  25 590-594
• 39 Butcher E C, Picker L J. Lymphocyte homing and homeostasis.  Science. 1996;  272 60-66
• 40 Wong J, Johnston B, Lee S S et al.. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature.  J Clin Invest. 1997;  99 2782-2790
• 41 Campbell J J, Qin S, Bacon K B, Mackay C R, Butcher E C. Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells.  J Cell Biol. 1996;  134 255-266
• 42 Lalor P F, Shields P, Grant A, Adams D H. Recruitment of lymphocytes to the human liver.  Immunol Cell Biol. 2002;  80 52-64
• 43 Adams D H, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.  Nat Rev Immunol. 2006;  6 244-251
• 44 Lalor P H, Faint J, Aarbodem Y, Hubscher S G, Adams D H. The role of cytokines and chemokines in the development of steatohepatitis.  Semin Liver Dis. 2007;  27 173-193
• 45 Desmet V J, Gerber M, Hoofnagle J H, Manns M, Scheuer P J. Classification of chronic hepatitis: diagnosis, grading and staging.  Hepatology. 1994;  19 1513-1520
• 46 Steinhoff G, Behrend M, Schrader B, Duijvestijn A M, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia-lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3.  Am J Pathol. 1993;  142 481-488
• 47 Lalor P F, Lai W K, Curbishley S M, Shetty S, Adams D H. Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.  World J Gastroenterol. 2006;  12 5429-5439
• 48 McNab G, Reeves J L, Salmi M, Hubscher S, Jalkanen S, Adams D H. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium.  Gastroenterology. 1996;  110 522-528
• 49 Lalor P F, Sun P J, Weston C J, Martin-Santos A, Wakelam M J, Adams D H. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion.  Hepatology. 2007;  45 465-474
• 50 Lalor P F, Edwards S, McNab G, Salmi M, Jalkanen S, Adams D H. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.  J Immunol. 2002;  169 983-992
• 51 Bonder C S, Norman M U, Swain M G et al.. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1.  Immunity. 2005;  23 153-163
• 52 Boisvert J, Kunkel E J, Campbell J J, Keeffe E B, Butcher E C, Greenberg H B. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes.  J Hepatol. 2003;  38 67-75
• 53 Shields P L, Morland C M, Salmon M, Qin S, Hubscher S G, Adams D H. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.  J Immunol. 1999;  163 6236-6243
• 54 Murai M, Yoneyama H, Harada A et al.. Active participation of CCR5( + )CD8( + ) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.  J Clin Invest. 1999;  104 49-57
• 55 Ajuebor M N, Hogaboam C M, Le T, Proudfoot A E, Swain M G. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4( + ) T cells to the liver.  Eur J Immunol. 2004;  34 2907-2918
• 56 Harvey C E, Post J J, Palladinetti P et al.. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.  J Leukoc Biol. 2003;  74 360-369
• 57 Geissmann F, Cameron T O, Sidobre S et al.. Intravascular immune surveillance by CXCR6 + NKT cells patrolling liver sinusoids.  PLoS Biol. 2005;  3 e113
• 58 Heydtmann M, Lalor P F, Eksteen J A, Hubscher S G, Briskin M, Adams D H. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver.  J Immunol. 2005;  174 1055-1062
• 59 Probert C S, Christ A D, Saubermann L J et al.. Analysis of human common bile duct-associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition.  J Immunol. 1997;  158 1941-1948
• 60 Adams D H, Afford S C. Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection.  Semin Liver Dis. 2005;  25 281-297
• 61 Nishio A, Keeffe E B, Gershwin M E. Immunopathogenesis of primary biliary cirrhosis.  Semin Liver Dis. 2002;  22 291-302
• 62 O'Mahony C A, Vierling J M. Etiopathogenesis of primary sclerosing cholangitis.  Semin Liver Dis. 2006;  26 3-21
• 63 Morland C M, Fear J, McNab G, Joplin R, Adams D H. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro.  Proc Assoc Am Physicians. 1997;  109 372-382
• 64 Leon M P, Bassendine M F, Wilson J L, Ali S, Thick M, Kirby J A. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4 + T cells.  Hepatology. 1996;  24 561-567
• 65 Chen X M, O'Hara S P, Nelson J B et al.. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB.  J Immunol. 2005;  175 7447-7456
• 66 Isse K, Harada K, Zen Y et al.. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.  Hepatology. 2005;  41 506-516
• 67 Efsen E, Grappone C, Defranco R M et al.. Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans.  J Hepatol. 2002;  37 39-47
• 68 Wilbanks A, Zondlo S C, Murphy K et al.. Expression cloning of the strl33/bonzo/tymstr ligand reveals elements of cc, cxc, and cx3c chemokines.  J Immunol. 2001;  166 5145-5154
• 69 Kim C H, Kunkel E J, Boisvert J et al.. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential.  J Clin Invest. 2001;  107 595-601
• 70 Sato T, Thorlacius H, Johnston B et al.. Role for CXCR6 in recruitment of activated CD8 + lymphocytes to inflamed liver.  J Immunol. 2005;  174 277-283
• 71 Drayton D L, Liao S, Mounzer R H, Ruddle N H. Lymphoid organ development: from ontogeny to neogenesis.  Nat Immunol. 2006;  7 344-353
• 72 Yoneyama H, Ichida T. Recruitment of dendritic cells to pathological niches in inflamed liver.  Med Mol Morphol. 2005;  38 136-141
• 73 Grant A J, Goddard S, Ahmed-Choudhury J et al.. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.  Am J Pathol. 2002;  160 1445-1455
• 74 Murakami J, Shimizu Y, Kashii Y et al.. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.  Hepatology. 1999;  30 143-150
• 75 Pope C, Kim S K, Marzo A et al.. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection.  J Immunol. 2001;  166 3402-3409
• 76 Agace W W. Tissue-tropic effector T cells: generation and targeting opportunities.  Nat Rev Immunol. 2006;  6 682-692
• 77 Eksteen B, Grant A J, Miles A et al.. Hepatic endothelial CCL25 mediates the recruitment of CCR9 + gut-homing lymphocytes to the liver in primary sclerosing cholangitis.  J Exp Med. 2004;  200 1511-1517
• 78 Grant A J, Lalor P F, Hubscher S G, Briskin M, Adams D H. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).  Hepatology. 2001;  33 1065-1072
• 79 Mora J R, Iwata M, Eksteen B et al.. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells.  Science. 2006;  314 1157-1160
• 80 Murai M, Yoneyama H, Ezaki T et al.. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction.  Nat Immunol. 2003;  4 154-160
• 81 Petrovic A, Alpdogan O, Willis L M et al.. LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.  Blood. 2004;  103 1542-1547
• 82 Henkart P A. CTL effector functions.  Semin Immunol. 1997;  9 85-86
• 83 Guicciardi M E, Gores G J. Cheating death in the liver.  Nat Med. 2004;  10 587-588
• 84 Abougergi M S, Gidner S J, Spady D K, Miller B C, Thiele D L. Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection.  Hepatology. 2005;  41 97-105
• 85 Kafrouni M I, Brown G R, Thiele D L. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.  J Immunol. 2001;  167 1566-1574
• 86 Tilg H, Diehl A M. Cytokines in alcoholic and nonalcoholic steatohepatitis.  N Engl J Med. 2000;  343 1467-1476
• 87 Tsukamoto H, Lu S C. Current concepts in the pathogenesis of alcoholic liver injury.  FASEB J. 2001;  15 1335-1349
• 88 Li Z, Lin H, Yang S, Diehl A M. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system.  Gastroenterology. 2002;  123 1304-1310
• 89 Fox-Robichaud A, Kubes P. Molecular mechanisms of tumor necrosis factor alpha-stimulated leukocyte recruitment into the murine hepatic circulation.  Hepatology. 2000;  31 1123-1127
• 90 Wolf D, Hallmann R, Sass G et al.. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis.  J Immunol. 2001;  166 1300-1307
• 91 Wang Y, Singh R, Lefkowitch J H, Rigoli R M, Czaja M J. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.  J Biol Chem. 2006;  281 15258-15267
• 92 Schwabe R F, Brenner D A. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways.  Am J Physiol Gastrointest Liver Physiol. 2006;  290 G583-G589
• 93 Alpini G, Ueno Y, Tadlock L et al.. Increased susceptibility of cholangiocytes to tumor necrosis factor-alpha cytotoxicity after bile duct ligation.  Am J Physiol Cell Physiol. 2003;  285 C183-C194
• 94 Streetz K, Leifeld L, Grundmann D et al.. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure.  Gastroenterology. 2000;  119 446-460
• 95 Plumpe J, Malek N P, Bock C T, Rakemann T, Manns M P, Trautwein C. NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration.  Am J Physiol Gastrointest Liver Physiol. 2000;  278 G173-G183
• 96 Liedtke C, Trautwein C. A protective role of Stat3 in Fas mediated apoptosis of the liver.  J Hepatol. 2004;  40 874-875
• 97 Luedde T, Trautwein C. Intracellular survival pathways in the liver.  Liver Int. 2006;  26 1163-1174
• 98 Afford S C, Randhawa S, Eliopoulos A G, Hubscher S G, Young L S, Adams D H. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection.  J Exp Med. 1999;  189 441-446
• 99 Grell M, Zimmermann G, Gottfried E et al.. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.  EMBO J. 1999;  18 3034-3043
• 100 Afford S C, Ahmed-Choudhury J, Randhawa S et al.. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.  FASEB J. 2001;  15 2345-2354
• 101 Ahmed-Choudhury J, Russell C L, Randhawa S et al.. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.  Mol Biol Cell. 2003;  14 1334-1345
• 102 Kusters S, Tiegs G, Alexopoulou L et al.. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis.  Eur J Immunol. 1997;  27 2870-2875
• 103 Ahmed-Choudhury J, Williams K T, Young L S, Adams D H, Afford S C. CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2.  Cell Signal. 2006;  18 456-468
• 104 Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity.  Trends Immunol. 2004;  25 280-288
• 105 Guillonneau C, Louvet C, Renaudin K et al.. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.  J Immunol. 2004;  172 1619-1629
• 106 Mehling A, Loser K, Varga G et al.. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity.  J Exp Med. 2001;  194 615-628
• 107 Kiener P A, Moran-Davis P, Rankin B M, Wahl A F, Aruffo A, Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes.  J Immunol. 1995;  155 4917-4925
• 108 Yellin M J, Winikoff S, Fortune S M et al.. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation.  J Leukoc Biol. 1995;  58 209-216
• 109 Zhou F, Ajuebor M N, Beck P L, Le T, Hogaboam C M, Swain M G. CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis.  Hepatology. 2005;  42 372-380
• 110 Brodeur S R, Angelini F, Bacharier L B et al.. C4b-binding protein (C4BP) activates B cells through the CD40 receptor.  Immunity. 2003;  18 837-848
• 111 Blom A M, Villoutreix B O, Dahlback B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?.  Mol Immunol. 2004;  40 1333-1346
• 112 Williams K T, Young S P, Negus A, Young L S, Adams D H, Afford S C. C4b binding protein binds to CD154 preventing CD40 mediated cholangiocyte apoptosis: a novel link between complement and epithelial cell survival.  PLoS ONE.. 2007;  2 e159
• 113 Diehl G E, Yue H H, Hsieh K et al.. TRAIL-R as a negative regulator of innate immune cell responses.  Immunity. 2004;  21 877-889
• 114 Liu Y G, Liu S X, Liang X H et al.. Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model.  Biochem Biophys Res Commun. 2007;  352 329-334
• 115 Liang X, Liu Y, Zhang Q et al.. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax.  J Immunol. 2007;  178 503-510
• 116 Mundt B, Wirth T, Zender L et al.. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.  Gut. 2005;  54 1590-1596
• 117 Maini M K, Boni C, Lee C K et al.. The role of virus-specific CD8( + ) cells in liver damage and viral control during persistent hepatitis B virus infection.  J Exp Med. 2000;  191 1269-1280
• 118 Dunn C, Brunetto M, Reynolds G et al.. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.  J Exp Med. 2007;  204 667-680
• 119 Kimberley F C, Screaton G R. Following a TRAIL: update on a ligand and its five receptors.  Cell Res. 2004;  14 359-372
• 120 O'Connor G M, Hart O M, Gardiner C M. Putting the natural killer cell in its place.  Immunology. 2006;  117 1-10
• 121 Sitia G, Isogawa M, Iannacone M, Campbell I L, Chisari F V, Guidotti L G. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.  J Clin Invest. 2004;  113 1158-1167
• 122 Sitia G, Isogawa M, Kakimi K, Wieland S F, Chisari F V, Guidotti L G. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes.  Proc Natl Acad Sci U S A. 2002;  99 13717-13722
• 123 Tough D F, Borrow P, Sprent J. Induction of bystander T-cell proliferation by viruses and type-i interferon in-vivo.  Science. 1996;  272 1947-1950
• 124 Adams D H, Hubscher S G. Systemic viral infections and collateral damage in the liver.  Am J Pathol. 2006;  168 1057-1059
• 125 Polakos N K, Cornejo J C, Murray D A et al.. Kupffer cell-dependent hepatitis occurs during influenza infection.  Am J Pathol. 2006;  168 1169-1178
• 126 Duchini A, Hendry R M, Redfield D C, Pockros P J. Influenza infection in patients before and after liver transplantation.  Liver Transpl. 2000;  6 531-542
• 127 Mehal W Z, Juedes A E, Crispe I N. Selective retention of activated CD8 + T cells by the normal liver.  J Immunol. 1999;  163 3202-3210
• 128 Ward S M, Jonsson J R, Sierro S et al.. Virus-specific CD8 + T lymphocytes within the normal human liver.  Eur J Immunol. 2004;  34 1526-1531
• 129 Klein C, Wustefeld T, Assmus U et al.. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.  J Clin Invest. 2005;  115 860-869
• 130 Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation.  N Engl J Med. 1999;  340 448-454
• 131 Tilg H, Moschen A R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity.  Nat Rev Immunol. 2006;  6 772-783
• 132 Verma S, Li S H, Wang C H et al.. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction.  Circulation. 2003;  108 736-740
• 133 Tsuchihashi S, Livhits M, Zhai Y, Busuttil R W, Araujo J A, Kupiec-Weglinski J W. Basal rather than induced heme oxygenase-1 levels are crucial in the antioxidant cytoprotection.  J Immunol. 2006;  177 4749-4757
• 134 Poss K D, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells.  Proc Natl Acad Sci U S A. 1997;  94 10925-10930
• 135 Tejima K, Arai M, Ikeda H et al.. Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells in rats.  Gastroenterology. 2004;  127 1488-1496
• 136 McNally S J, Harrison E M, Ross J A, Garden O J, Wigmore S J. Curcumin induces heme oxygenase-1 in hepatocytes and is protective in simulated cold preservation and warm reperfusion injury.  Transplantation. 2006;  81 623-626
• 137 Sass G, Seyfried S, Parreira S M et al.. Cooperative effect of biliverdin and carbon monoxide on survival of mice in immune-mediated liver injury.  Hepatology. 2004;  40 1128-1135
• 138 Shen X D, Ke B, Zhai Y et al.. CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection.  Transplantation. 2002;  74 315-319
• 139 Yamashita K, Ollinger R, McDaid J et al.. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs.  FASEB J. 2006;  20 776-778
• 140 Prinz I, Zerrahn J, Kaufmann S H, Steinhoff U. Promiscuous peptide recognition of an autoreactive CD8( + ) T-cell clone is responsible for autoimmune intestinal pathology.  J Autoimmun. 2002;  18 281-287
• 141 Yu J, Ip E, Dela P A et al.. COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator.  Hepatology. 2006;  43 826-836
• 142 Serhan C N, Brain S D, Buckley C D et al.. Resolution of inflammation: state of the art, definitions and terms.  FASEB J. 2007;  21 325-332
• 143 Levy B D, Clish C B, Schmidt B, Gronert K, Serhan C N. Lipid mediator class switching during acute inflammation: signals in resolution.  Nat Immunol. 2001;  2 612-619
• 144 Henderson N C, Iredale J P. Liver fibrosis: cellular mechanisms of progression and resolution.  Clin Sci (Lond). 2007;  112 265-280
• 145 Friedman S L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.  J Biol Chem. 2000;  275 2247-2250
• 146 Duffield J S, Forbes S J, Constandinou C M et al.. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.  J Clin Invest. 2005;  115 56-65
• 147 Novobrantseva T I, Majeau G R, Amatucci A et al.. Attenuated liver fibrosis in the absence of B cells.  J Clin Invest. 2005;  115 3072-3082
• 148 Harris D P, Haynes L, Sayles P C et al.. Reciprocal regulation of polarized cytokine production by effector B and T cells.  Nat Immunol. 2000;  1 475-482
• 149 Safadi R, Ohta M, Alvarez C E et al.. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.  Gastroenterology. 2004;  127 870-882
• 150 Chiaramonte M G, Donaldson D D, Cheever A W, Wynn T A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.  J Clin Invest. 1999;  104 777-785